Having had two surgeries and one round of radiotherapy it is now being proposed that I should have immunotherapy with cemiplimab to treat the skin cancer that seems to keep travelling around my head neck. My concern about this, quite apart from the possible "ordinary" side effects that goes with it, I also have Relapsing Remitting MS which had been being treated with Ocrevus until my cancer was discovered when it was stopped. It seems the makers of Ocrevus are concerned about patients with cancer. Now I'm reading that the manufacturers of cemiplimab were concerned about patients with neurological problems that they were excluded from any clinical trials. I really need guidance here about the wisdom of going ahead with this treatment or going back to the oncology team for their next best suggestion.
